BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 29620699)

  • 21. Retrospective evaluation of therapeutic drug monitoring of clozapine and norclozapine in Belgium using a multidrug UHPLC-MS/MS method.
    Patteet L; Maudens KE; Vermeulen Z; Dockx G; De Doncker M; Morrens M; Sabbe B; Neels H
    Clin Biochem; 2014 Dec; 47(18):336-9. PubMed ID: 25289972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population.
    Wang ZZ; Deng SH; Lu HY; Li L; Zhu XQ; Hu JQ; Xie HS; Chen HZ; Chen YQ; Zhang M; Fang ZY; Wen YG; Shang DW
    Hum Psychopharmacol; 2020 May; 35(3):e2733. PubMed ID: 32239743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quetiapine and drug interactions: evidence from a routine therapeutic drug monitoring service.
    Castberg I; Skogvoll E; Spigset O
    J Clin Psychiatry; 2007 Oct; 68(10):1540-5. PubMed ID: 17960969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
    Albitar O; Harun SN; Sheikh Ghadzi SM
    CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of clozapine and norclozapine levels with patient and therapy characteristics-focus on interaction with valproic acid.
    Panić B; Jovanović M; Lukić V; Vučićević K; Miljković B; Milovanović S
    Eur J Clin Pharmacol; 2023 Nov; 79(11):1557-1564. PubMed ID: 37733278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of valproic acid and the antidepressant drugs doxepin and venlafaxine: analysis of therapeutic drug monitoring data under naturalistic conditions.
    Unterecker S; Reif A; Hempel S; Proft F; Riederer P; Deckert J; Pfuhlmann B
    Int Clin Psychopharmacol; 2014 Jul; 29(4):206-11. PubMed ID: 24374906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of post-mortem changes on peripheral and central whole blood and tissue clozapine and norclozapine concentrations in the domestic pig (Sus scrofa).
    Flanagan RJ; Amin A; Seinen W
    Forensic Sci Int; 2003 Mar; 132(1):9-17. PubMed ID: 12689746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients: A literature review and a case series of 17 patients from 3 studies.
    Ruan CJ; Olmos I; Ricciardi C; Schoretsanitis G; Vincent PD; Anıl Yağcıoğlu AE; Eap CB; Baptista T; Clark SR; Fernandez-Egea E; Kim SH; Lane HY; Leung J; Maroñas Amigo O; Motuca M; Every-Palmer S; Procyshyn RM; Rohde C; Suhas S; Schulte PFJ; Spina E; Takeuchi H; Verdoux H; Correll CU; Molden E; De Las Cuevas C; de Leon J
    Schizophr Res; 2024 Jun; 268():293-301. PubMed ID: 37487869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic Drug-Drug Interactions of Mood Stabilizers and Risperidone in Patients Under Combined Treatment.
    Schoretsanitis G; Haen E; Gründer G; Stegmann B; Schruers KR; Hiemke C; Lammertz SE; Paulzen M
    J Clin Psychopharmacol; 2016 Dec; 36(6):554-561. PubMed ID: 27811552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
    Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
    J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple-dose pharmacokinetics of clozapine in patients with chronic schizophrenia.
    Guitton C; Abbar M; Kinowski JM; Chabrand P; Bressolle F
    J Clin Psychopharmacol; 1998 Dec; 18(6):470-6. PubMed ID: 9864080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Chinese medicine called Danggui Longhui may be a new clinically relevant clozapine inducer: Two case reports identified by therapeutic drug monitoring.
    Jia F; Zang YN; Ruan CJ; Chi L; Zhuang HY; Wan Z; Yang Q; de Leon J
    Schizophr Res; 2024 Jun; 268():308-311. PubMed ID: 37775404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentrations in plasma clozapine levels in schizophrenic and schizoaffective patients.
    Iglesias García C; Iglesias Alonso A; Bobes J
    Rev Psiquiatr Salud Ment; 2017; 10(4):192-196. PubMed ID: 28844295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Examining concentration-dependent toxicity of clozapine: role of therapeutic drug monitoring.
    Khan AY; Preskorn SH
    J Psychiatr Pract; 2005 Sep; 11(5):289-301. PubMed ID: 16184070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hypertriglyceridemia on the pharmacokinetics and blood-brain barrier penetration of clozapine and norclozapine following administration to rats.
    Gershkovich P; Sivak O; Sharma A; Barr AM; Procyshyn R; Wasan KM
    Eur Neuropsychopharmacol; 2010 Aug; 20(8):545-52. PubMed ID: 20163937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pregabalin-associated elevation of clozapine serum levels.
    Gahr M; Schmid MM; Schönfeldt-Lecuona C
    Pharmacopsychiatry; 2012 Nov; 45(7):297-9. PubMed ID: 22473300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Systematic Review of Clozapine Concentration-Dose Ratio from Therapeutic Drug Monitoring Studies in Children and Adolescents Treated with Clozapine for Mental Disorders.
    Jiménez-Fernández S; Gurpegui M; Correll CU; de Leon J; Schoretsanitis G
    Ther Drug Monit; 2024 Apr; 46(2):170-180. PubMed ID: 38018845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of patient-specific factors on clozapine metabolism in individuals with treatment-resistant schizophrenia or schizoaffective disorder.
    Rafizadeh R; Sooch A; Risi A; Bihelek N; Kanegawa K; Barr AM; White RF; Schütz CG; Bousman CA
    J Psychopharmacol; 2024 Jun; 38(6):526-531. PubMed ID: 38520287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data.
    Ding J; Zhang Y; Zhang Y; Yang L; Zhang S; Cui X; Meng Z; Li Y; Xing H
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):552-559. PubMed ID: 36286707
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunct divalproex or lithium to clozapine in treatment-resistant schizophrenia.
    Kelly DL; Conley RR; Feldman S; Yu Y; McMahon RP; Richardson CM
    Psychiatr Q; 2006; 77(1):81-95. PubMed ID: 16397757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.